Tachykinins increase [3H]acetylcholine release in mouse striatum through multiple receptor subtypes

Neuroscience

Volumn 95, Issue 2, 1999, Pages 367-376

  Preston, Z ^a   Lee, K ^a   Widdowson, L ^a   Richardson, P J ^a   Pinnock, R D ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Acetylcholine; Interneuron; Striatum; Tachykinin

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; 2 [1 (3 AMIDINOTHIOPROPYL) 1H INDOL 3 YL] 3 (1 METHYL 1H INDOL 3 YL)MALEIMIDE; ACETYLCHOLINE; BENZOYLALANYLALANYL DEXTRO TRYPTOPHYLPHENYLALANYL DEXTRO PROLYLPROLYLNORLEUCINAMIDE; CHELERYTHRINE; MESSENGER RNA; NOLPITANTIUM; OSANETANT; SENKTIDE; SUBSTANCE P; TACHYKININ; TACHYKININ RECEPTOR; TACHYKININ RECEPTOR AGONIST; TACHYKININ RECEPTOR ANTAGONIST; 1 (6 ((3 METHOXYESTRA 1,3,5(10) TRIEN 17 YL)AMINO)HEXYL) 1H PYRROLE 2,5 DIONE; 1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 2,5 PYRROLIDINEDIONE; 1-(6-((3-METHOXYESTRA-1,3,5(10)-TRIEN-17-YL)AMINO)HEXYL)-1H-PYRROLE-2,5-DIONE; 2 AMINO 5 PHOSPHONOVALERIC ACID; 2 PYRROLIDONE DERIVATIVE; 2,3 DIOXO 6 NITRO 7 SULFAMOYLBENZO(F)QUINOXALINE; 2,3-DIOXO-6-NITRO-7-SULFAMOYLBENZO(F)QUINOXALINE; ALKALOID; AMINO ACID RECEPTOR BLOCKING AGENT; BENZOPHENANTHRIDINE DERIVATIVE; CHOLINE ACETYLTRANSFERASE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; ENZYME INHIBITOR; ESTRANE DERIVATIVE; INDOLE DERIVATIVE; N(G) METHYLARGININE; NEUROKININ 1 RECEPTOR; NEUROKININ 2 RECEPTOR; NEUROKININ 3 RECEPTOR; NEUROKININ A; NEUROKININ A (4 10), BETA ALA(8); NEUROKININ A (4-10), BETA-ALA(8)-; OLIGOPEPTIDE; PEPTIDE FRAGMENT; PHENANTHRIDINE DERIVATIVE; PHOSPHODIESTERASE INHIBITOR; PIPERIDINE DERIVATIVE; QUINOXALINE DERIVATIVE; QUINUCLIDINE DERIVATIVE; RO 31-8220; SUBSTANCE P, SAR(9) MET(O2)(11); SUBSTANCE P, SAR(9)-MET(O2)(11)-; TETRODOTOXIN; TRITIUM;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; CONTROLLED STUDY; CORPUS STRIATUM; ELECTROPHYSIOLOGY; MOUSE; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; ANIMAL; ARTICLE; C57BL MOUSE; CELL MEMBRANE POTENTIAL; CHEMISTRY; DRUG ANTAGONISM; DRUG EFFECT; ENZYMOLOGY; GENETICS; IN SITU HYBRIDIZATION; INTERNEURON; METABOLISM; PHYSIOLOGY; SIGNAL TRANSDUCTION;

2-AMINO-5-PHOSPHONOVALERATE; ACETYLCHOLINE; ALKALOIDS; ANIMALS; BENZOPHENANTHRIDINES; CHOLINE O-ACETYLTRANSFERASE; CORPUS STRIATUM; ELECTROPHYSIOLOGY; ENZYME INHIBITORS; ESTRENES; EXCITATORY AMINO ACID ANTAGONISTS; IN SITU HYBRIDIZATION; INDOLES; INTERNEURONS; MEMBRANE POTENTIALS; MICE; MICE, INBRED C57BL; NEUROKININ A; OLIGOPEPTIDES; OMEGA-N-METHYLARGININE; PEPTIDE FRAGMENTS; PHENANTHRIDINES; PHOSPHODIESTERASE INHIBITORS; PIPERIDINES; PYRROLIDINONES; QUINOXALINES; QUINUCLIDINES; RECEPTORS, NEUROKININ-1; RECEPTORS, NEUROKININ-2; RECEPTORS, NEUROKININ-3; RECEPTORS, TACHYKININ; RNA, MESSENGER; SIGNAL TRANSDUCTION; SUBSTANCE P; TACHYKININS; TETRODOTOXIN; TRITIUM;

EID: 0033627927     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(99)00440-6     Document Type: Article

References (54)

1. Aosaki T., Kawaguchi Y. Actions of substance P on rat neostriatal neurons in vitro. J. Neurosci. 16:1996;5141-5153.
2. Arenas E., Alberch J., Perez Navarro E., Solsona C., Marsal J. Neurokinin receptors differentially mediate endogenous acetylcholine release evoked by tachykinins in the neostriatum. J. Neurosci. 11:1991;2332-2338.
3. Augood S.J., Faull R.L., Love D.R., Emson P.C. Reduction in enkephalin and substance P messenger RNA in the striatum of early grade Huntington's disease: a detailed cellular in situ hybridization study. Neuroscience. 72:1996;1023-1036.
4. Beaujouan J.C., Saffroy M., Torrens Y., Glowinski J. Potency and selectivity of the tachykinin NK3 receptor antagonist SR 142801. Eur. J. Pharmac. 319:1997;307-316.
5. Bell M.I., Richardson P., Lee K. Characterisation of the mechanism of action of tachykinins in the rat striatal cholinergic interneurons. Neuroscience. 87:1998;649-658.
6. Bolam J.P., Ingham C.A., Izzo P.N., Levey A.I., Rye D.B., Smith A.D., Wainer B.H. Substance P-containing terminals in synaptic contact with cholinergic neurons in the neostriatum and basal forebrain: a double immunocytochemical study in the rat. Brain Res. 397:1986;279-289.
7. Croci T., Landi M., Emonds-Alt X., Le-Fur G., Manara L. In vitro characterisation of the non-peptide tachykinin NK-1 and NK-2 receptor antagonists, SR140333 and SR48968, in different rat and guinea-pig intestinal segments. Life Sci. 56:1995;267-275.
8. De Felipe C., Herrero J.F., O'Brien J.A., Palmer J.A., Doyle C.A., Smith A.J., Laird J.M., Belmonte C., Cervero F., Hunt S.P. Altered nociception, analgesia and aggression in mice lacking the receptor for substance P. Nature. 392:1998;394-397.
9. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends Neurosci. 17:1994;228-233.
10. Dixon A.K., Richardson P.J., Lee K., Carter N.P., Freeman T.C. Expression profiling of single cells using 3′ end amplification (TPEA) PCR. Nucleic Acids Res. 26:1998;4426-4431.
11. Emonds-Alt X., Doutremepuich J.D., Heaulme M., Neliat G., Santucci V., Steinberg R., Vilain P., Bichon D., Ducoux J.P., Proietto V., et al. In vitro and in vivo biological activities of SR140333, a novel potent non-peptide tachykinin NK1 receptor antagonist. Eur. J. Pharmac. 250:1993;403-413.
12. Emonds-Alt X., Bichon D., Ducoux J.P., Heaulme M., Miloux B., Poncelet M., Proietto V., Van-Broeck D., Vilain P., Neliat G. SR142801, the first potent non-peptide antagonist of the tachykinin NK-3 recptor. Life Sci. 56:1995;PL27-PL32.
13. Exton J.H. Phosphatidylcholine breakdown and signal transduction. Biochim. biophys. Acta. 1212:1994;26-42.
14. Fukuhara S., Mukai H., Kako K., Nakayama Y., Munekata E. Further identification of neurokinin receptor types and mechanisms of calcium signalling evoked by neurokinins in the murine neuroblastoma C1300 cell line. J. Neurochem. 67:1996;1282-1292.
15. Garret C., Carruette A., Fardin V., Moussaoui S., Peyronel J.F., Blanchard J.C., Laduron P.M. Pharmacological properties of a potent and selective non-peptide substance P antagonist. Proc. natn. Acad. Sci. U.S.A. 88:1991;10,208-10,212.
16. Gerfen C.R. Substance P (neurokinin-1) receptor mRNA is selectively expressed in cholinergic neurons in the striatum and basal forebrain. Brain Res. 556:1991;165-170.
17. Guard S., Watson S.P. Tachykinin receptor types: classification and membrane signalling mechanisms. Neurochem. Int. 18:1991;149-165.
18. Guillemain I., Rollandy I., Imhoff V., Rossignol B. The NK-1 receptor and a calcium-phospholipid pathway: inositol trisphosphate production and calcium movements induced by selective agonists of neurokinin receptors in rat parotid glands. J. Neurochem. 58:1992;2321-2325.
19. Hagan R.M., Beresford I.J., Stables J., Dupere J., Stubbs C.M., Elliott P.J., Sheldrick R.L., Chollet A., Kawashima E., McElroy A.B. Characterisation, CNS distribution and function of NK2 receptors studied using potent NK2 receptor antagonists. Regul. Pept. 46:1993;9-19.
20. Hershey A.D., Krause J.E. Molecular characterization of a functional cDNA encoding the rat substance P receptor. Science. 247:1990;958-962.
21. Holt D.J., Graybiel A.M., Saper C.B. Neurochemical architecture of the human striatum. J. comp. Neurol. 384:1997;1-25.
22. Huang R.R., Cheung A.H., Mazina K.E., Strader C.D., Fong T.M. cDNA sequence and heterologous expression of the human neurokinin-3 receptor. Biochem. biophys. Res. Commun. 184:1992;966-972.
23. Ishii K., Oda Y., Ichikawa T., Deguchi T. Complementary DNAs for choline acetyltransferase from spinal cords of rat and mouse: nucleotide sequences, expression in mammalian cells, and in situ hybridization. Molec. Brain Res. 7:1990;151-159.
24. Jiang Z.G., North R.A. Membrane properties and synaptic responses of rat striatal neurones in vitro. J. Physiol. 443:1991;533-553.
25. Jin S., Johansson B., Fredholm B.B. Effects of adenosine A1 and A2 receptor activation on electrically evoked dopamine and acetylcholine release from rat striatal slices. J. Pharmac. exp. Ther. 267:1993;801-808.
26. Kage R., McGregor G.P., Thim L., Conlon J.M. Neuropeptide-gamma: a peptide isolated from rabbit intestine that is derived from gamma-preprotachykinin. J. Neurochem. 50:1988;1412-1417.
27. Kaneko T., Shigemoto R., Nakanishi S., Mizuno N. Substance P receptor-immunoreactive neurons in the rat neostriatum are segregated into somatostatinergic and cholinergic aspiny neurons. Brain Res. 631:1993;297-303.
28. Kawaguchi Y. Large aspiny cells in the matrix of the rat neostriatum in vitro: physiological identification, relation to the compartments and excitatory postsynaptic currents. J. Neurophysiol. 67:1992;1669-1682.
29. Kawaguchi Y. Physiological, morphological, and histochemical characterization of three classes of interneurons in rat neostriatum. J. Neurosci. 13:1993;4908-4923.
30. Kawaguchi Y., Wilson C.J., Augood S.J., Emson P.C. Striatal interneurones: chemical, physiological and morphological. Trends Neurosci. 18:1995;527-535.
31. Khawaja A.M., Rogers D.F. Tachykinins: receptor to effector. Int. J. Biochem. Cell Biol. 28:1996;721-738.
32. 3H]acetylcholine release. J. Neurochem. 62:1994;960-965.
33. Kowall N.W., Quigley B.J. Jr, Krause J.E., Lu F., Kosofsky B.E., Ferrante R.J. Substance P and substance P receptor histochemistry in human neurodegenerative diseases. Regul. Pept. 46:1993;174-185.
34. Kubota Y., Mikawa S., Kawaguchi Y. Neostriatal GABAergic interneurones contain NOS, calretinin or parvalbumin. NeuroReport. 5:1993;205-208.
35. ATP channel current present in striatal cholinergic interneurones. J. Physiol. 510:1998;441-453.
36. Mantyh P.W., Maggio J.E., Hunt S.P. The autoradiographic distribution of kassinin and substance K binding sites is different from the distribution of substance P binding sites in rat brain. Eur. J. Pharmac. 102:1984;361-364.
37. 14C choline into synaptosomes in vitro. Biochem. J. 110:1968;193-198.
38. Mauborgne A., Javoy-Agid F., Legrande J.C., Agid Y., Cervero F. Decrease of substance P-like immunoreactivity in the substantia nigra and pallidum of parkinsonian brains. Brain Res. 268:1983;167-170.
39. Mussap C.J., Geraghty D.P., Burcher E. Tachykinin receptors: a radioligand binding perspective. J. Neurochem. 60:1993;1987-2009.
40. Petitet F., Glowinski J., Beaujouan J.C. Evoked release of acetylcholine in the rat striatum by stimulation of tachykinin NK-1 receptors. Eur. J. Pharmac. 192:1991;203-204.
41. 3H]-acetylcholine release in mouse striatum through multiple receptor subtypes (abstract). J. Physiol. 513P:1998;24P.
42. Preston Z., Lee K., Richardson P.J., Pinnock R.D. Cholinergic interneurones in the mouse striatum express multiple tachykinin receptor subtypes (abstract). J. Physiol. 518P:1999;156P.
43. Saffroy M., Beujouan J., Torrens Y., Bessyre J., Bergstrom L., Glowinski J. Localization of tachykinin binding sites (NK-1, NK-2, NK-3 ligands) in the rat brain. Peptides. 9:1988;227-241.
44. Sakamoto S., Goto S., Ito H., Hirano A. Striosomal organization of substance P-like immunoreactivity in parkinsonian patients. Neurology. 42:1992;1071-1075.
45. Sasai Y., Nakanishi S. Molecular characterisation of rat substance K receptors and its mRNAs. Biochem. biophys. Res. Commun. 165:1989;695-702.
46. Shigemoto R., Yokota Y., Tsuchida K., Nakanishi S. Cloning and expression of a rat neuromedin K receptor cDNA. J. biol. Chem. 265:1990;623-628.
47. Shigemoto R., Nakaya Y., Nomura S., Ogawa Meguro R., Ohishi H., Kaneko T., Nakanishi S., Mizuno N. Immunocytochemical localization of rat substance P receptor in the striatum. Neurosci. Lett. 153:1993;157-160.
48. Steinberg R., Rodier D., Souiclhac J., Bougault I., Emonds-Alt X., Soubrie P., Le Fur G. Pharmacological characterization of tachykinin receptors controlling acetylcholine release from rat striatum: an in vivo microdialysis study. J. Neurochem. 65:1995;2543-2548.
49. 3H]senktide. Brain Res. 534:1990;1-7.
50. Stoessl A.J. Localization of striatal and nigral tachykinin receptors in the rat. Brain Res. 646:1994;13-18.
51. Takano K., Stanfield P.R., Nakajima S., Nakajima Y. Protein kinase C-mediated inhibition of an inward rectifier potassium channel by substance P in nucleus basalis neurons. Neuron. 14:1995;999-1008.
52. Tatemoto K., Lundberg J.M., Jornvall H., Mutt V. Neuropeptide K: isolation, structure and biological activities of a novel brain tachykinin. Biochem. biophys. Res. Commun. 128:1985;947-953.
53. Torrens Y., Beujouan J., Saffroy M., Glowinski J., Tence M. Functional coupling of the NK-1 tachykinin receptor to phospholipase D in Chinese hamster ovary cells and astrocytoma cells. J. Neurochem. 70:1998;2091-2098.
54. Tremblay L., Kemel M.L., Desban M., Gauchy C., Glowinski J. Distinct presynaptic control of dopamine release in striosomal- and matrix-enriched areas of the rat striatum by selective agonists of NK1, NK2, and NK3 tachykinin receptors. Proc. natn. Acad. Sci. U.S.A. 89:1992;11,214-11,218.